Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Teva’s API business reports fall in sales
2:07 AM MST | February 7, 2014 | Deepti Ramesh
The active pharmaceutical ingredient (API) business of Teva Pharmaceutical Industries (Petaḥ Tiqwa, Israel) reports a 19.3% fall in sales in the fourth quarter of 2013, compared with the fourth quarter of 2012, to $163 million. For the full year 2013, the API business reports a 13% fall in sales, compared with 2012, to $692 million. Earnings figures for the API business were not disclosed. Teva has the largest API business in the world in terms of...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee